Germany Anti-Infective Industry Outlook 2022 - 2026

Key Market Indicators

In 2021, the country came in number 3, the United States was ahead with $980,940,000. France, the UK and China respectively were numbers 2, 3 and 4 in this ranking. Sales of German antiinfective medicine are set to reach $3.74 billion by 2026, up from $3.56 billion in 2021. This represents an average annual growth rate of 1.1%. Since 1991, the German market has experienced a 0.1% year-on-year decline. In 2021, the country came in second place behind the United Kingdom, which had sales of $3.56 billion. South Korea, Italy and France rounded out the top five. German exports of antibiotics are projected to reach $48.5 million by 2026, down from $78.1 million in 2021, representing an average annual decline of 7.5%. Since 1996, German supply has decreased by 8.5% year on year. In 2021, the country was placed fifteenth, with the Netherlands taking the lead at $78.1 million. Switzerland, Italy and India were second, third and fourth in the ranking, respectively. German imports of antibiotics are expected to reach $1.01 billion by 2026, growing 0.7% year on year. This marks an increase from $981 million in 2021. Since 1996, German demand has grown 3.9% year on year. In 2021, the country placed third behind the United States, which had imports of $981 million. France, the UK and China were second, third and fourth in the ranking, respectively.

Germany Anti-Infective Market Data and Forecasts

Improve your Knowledge with the latest Indicators and Trends

• Pharmaceuticals: Captivating Opportunities in the Expansive Antiemetics Sector

  The antiemetics market represents a significant segment within the pharmaceuticals industry that brims with potential for expanding its already considerable market share. A growing global population and the consequent increase in disease incidences have positively influenced the demand for antiemetics. The burgeoning healthcare sector in numerous developing economies has also...

  Discover more insights

• Diagnostics Industry: Unpacking Quidel's Market Performance, Competitive Strategy and Product Positioning

  Quidel Corporation, a major player in the diagnostic industry, has enjoyed a favorable market performance. The company has effectively capitalized on the increased demand for diagnostic tools and solutions, particularly amid the global pandemic. With a diverse product portfolio comprising rapid diagnostic tests, molecular diagnostic tests, and immunoassays, Quidel has...

  Discover more insights

• Chemical Industry: The Impending Growth and Evolution of the Global Cresol Market

  The global cresol market stands at the precipice of considerable expansion, propelled largely by increasing demand in end-use industries. Cresols, organic compounds largely derived from coal tar or petroleum, find significant usage in the manufacture of disinfectants, pesticides, resins, fragrances, and more. Rising urbanisation has spurred growth in sectors like...

  Discover more insights

• Chemical Industry: Unlocking Perspectives on Future Trends and Opportunities in Antistatic Agents Market

  As of now, the antistatic agents market is experiencing vital growth. Trends such as miniaturization in the electronics sector, coupled with the proliferation of polymer-based lightweight automotive components, are driving demand for antistatic agents. These compounds inhibit charge development on surfaces, a critical factor in preventing material failure. The widespread...

  Discover more insights

• Pharmaceutical Sector: Hydroxychloroquine Market Trends, Growth Prospects, and Future Forecasts

  The global demand for Hydroxychloroquine is primarily driven by its therapeutic applications in the treatment of autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis. However, the sudden surge in demand can be attributed to it being investigated as a potential medication for pandemic diseases, despite the absence of...

  Discover more insights